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The possible involvement of phosphoinositides’ turnover in the process of neurotransmitter elease in the 
central nervous system (CNS) was studied using rat brain slices and synaptosomes. A depolarizing concen- 
tration of potassium chloride (25 mM) induces an 8.6 f 0.45 increase of PHlnoradrenaline (PH]NA) frac- 
tional release in cerebral cortical slices above spontaneous release, and 15 mM KC1 induces a 3-fold increase 
of PH]NA release in rat brain synaptosomes. Neomycin, an aminoglycoside which binds phosphoinositides, 
inhibits the potassium-induced release in cortical slices with an IC,, =O.S + 0.07 mM and with I&=0.2 
f 0.03 mM in synaptosomes. Veratridine, a veratrum alkaloid which increases membrane permeability to 
sodium ions and causes depolarization of neuronal cells, induces a net 13.4 + 0.3% increase of PH]NA frac- 
tional release above spontaneous release in cortical slices. In analogy to K+ stimulaton, neomycin inhibits 
the veratridine-stimulated release in cortical slices with an IC,, = 0.65 f 0.1 mM. It appears that the recy- 
cling of phospoinositides, which is necessary for Ca2 + mobilization, participates in the Ca2 +-dependent in- 
duced neurotransmitter release in the central nervous systen. 
Release; Inositol triphosphate; Noradrenaline; Neomycin; (Rat brain slice) 
1. INTRODUCTION 
Neomycin, a polycationic antibiotic complex 
with nephrotoxic and ototoxic properties, interacts 
selectively with anionic phospholipids [l-4]. 
This aminoglycoside interacts specifically with 
phosphatidylinositol monophosphate (PIP) and 
PIP2, and inhibits their metabolism [5-81. Neo- 
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mycin was shown to decrease the amount and the 
32P-labeling of renal phosphatidylinositol bisphos- 
phate [7] and to inhibit the carbamylcholine break- 
down of phosphoinositides in membranes prepared 
from neonatal rat pancreatic islet cells [8]. Recent- 
ly, neomycin was shown to inhibit thrombin- 
stimulated inositol phosphate formation in human 
platelets [9], as well as the thrombin-stimulated 
phosphoinositide turnover and cell proliferation, 
in hamster fibroblast (NIL) cells [lo]. The thyro- 
tropin-releasing hormone stimulation of polyphos- 
phoinositide breakdown and prolactin release was 
shown to be effectively inhibited by neomycin in 
GH3 rat pituitary cells [I 11. Thus, neomycin, at 
low concentrations (0.05-l mM), can be used as a 
probe to study the involvement of phosphoinosit- 
ide metabolism in various cellular processes. In ad- 
dition, other Ca2+-dependent processes such as 
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histamine secretion from mast cells [12] and 
amylase secretion, stimulated by carbachol in 
permeabilized pancreatic acini [ 131, were shown to 
be inhibited by neomycin. PIP2 bound to 
neomycin is not cleaved by phospholipase C to give 
IP3 which mobilizes Ca*+ from internal stores, 
thus providing an explanation for neomycin’s in- 
hibitory action of Ca*+-dependent processes. Fur- 
thermore, it has recently been shown that 
neomycin also binds directly to IPs [14], which can 
explain its direct inhibitory effects of cellular pro- 
cesses which utilize intracellular Ca*+. 
In the present study, we looked at the effect of 
neomycin on two Ca’+-dependent release pro- 
cesses in the nervous system. We demonstrate that 
the stimulated release of [3H]NA from cerebral 
cortical slices either by high potassium ions, or by 
veratridine is inhibited by neomycin, and suggests 
a role for phosphoinositide metabolism in the 
stimulated release process. 
2. EXPERIMENTAL 
2.1. Chemicals 
[3H]Noradrenaline (19.7 Ci/mmol) was pur- 
chased from New England Nuclear (USA). Neo- 
mycin sulfate and veratridine were from Sigma 
(USA). All other reagents and salts were of the 
highest purity available. All solutions were 
prepared using double distilled water. 
2.2. [~HJNA release 
Male albino rats (150-200 g) were killed and 
their brains rapidly removed. Slices of cerebral 
cortex were prepared using a McIlwain tissue chop- 
per (350pm), and were allowed to equilibrate for 
15 min with an oxygenated solution (95% 02/5% 
COZ) Krebs-Henseleit, containing the following 
(mM): 118 NaCl; 4.7 KCl; 1.2 MgS04; 25 
NaHCOj; 1.0 Na2HPOd; 0.004 NazEDTA; and 
11.1 glucose, at 37°C. Subsequently, the slices 
were preincubated for 15 min with [3H]NA 19.7 
Ci/mmol, final concentration 0.25 ,uM, followed 
by 3 min washes with 3 ml of the oxygenated 
medium. The slices were distributed into superfu- 
sion chambers, containing 1 ml of the oxygenated 
solution, with an additional 1.3 mM CaClz. The 
spontaneous release of [3H]NA was monitored 
during 60 min at 10 min intervals. At t = 60 min, 
the slices were stimulated either by 25 mM KC1 
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(NaCl content in the medium was corrected accor- 
dingly) or 3 PM veratridine, for 10 min. Neomycin 
was added at t = 40 min, and was present in the 
assay throughout the experiment. At the end of the 
experiment, the remaining [3H]NA content of 
tissue was extracted with 1 ml of 0.1 N HCI. 
2.3. Analysis of release assay 
[3H]NA efflux during the 10 min collection 
period was expressed as the percentage of [3H]NA 
content of the slices at the beginning of the collec- 
ting interval. The net efflux of [3H]NA stimulated 
by either K+ or veratridine was determined by sub- 
tracting the spontaneous efflux of radioactivity 
from the total overflow, which includes one frac- 
tion after stimulation in the case of K+, and two 
fractions in the case of veratridine. In synap- 
tosomes, release by K+ was calculated in two frac- 
tions. Spontaneous [3H]NA release was about 
2-3% of total tissue content, and stimulated 
[3H]NA release was up to 8-10%. Each experiment 
was carried out in quadruplicate determinations. 
2.4. Preparation of cortical synaptosomes 
Male albino rats (150-200 g) were killed by 
decapitation, and the brains were rapidly removed 
and dissected at 4°C. The cortex (0.5 g) was ex- 
cised and homogenized (8 strokes) in 10 ml of 0.32 
M sucrose, 4pM EDTA, at 4”C, in a Teflon glass 
homogenizer (Hinkle & Kunkle). The homogenate 
was centrifuged at 1OOOxg for 10 min and the 
supernatant at 12OOOxg for 20 min. The pellet 
was collected and diluted to 20 ml final volume of 
Krebs-Henseliet buffer, containing (mM): 125 
NaCl; 3 KCl; 1.2 MgS04; 1.2 CaCl2; 1.2 NaHPO.,; 
25 NaHC03; 11.1 glucose, and 4 PM EDTA. The 
synaptosomes were preincubated with oxygenated 
Krebs-Henseliet buffer, 95% 02/5% CO2 at pH 
7.3, and loaded with 0.06 PM [3H]NA (19.7 
Ci/mmol) for 20 min, in the presence of 1 mM 
ATP and 1 PM GTP. Centrifugation at 6OOxg 
followed, and the synaptosomes were then diluted 
to a final concentration of 0.5 mg/ml. 
2.5. [3HJNA release in cortical synaptosomes 
The preloaded synaptosomes (11 .O mg protein) 
were layered on Sephadex G-15 in a final volume 
of 1.5 ml and incubated in oxygenated buffer for 
45 min. Protein was determined according to 
Lowry et al. [15] using bovine serum albumin as a 
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standard. The synaptosomes were stimulated with 
15 mM KC1 for 2 min and neomycin, at the in- 
dicated concentration, was added 8 min prior to 
the K+ stimulation. Efflux of radioactivity was 
monitored at intervals of 2 min. At the end of the 
experiment, total residual [3H]NA content was 
determined by extraction of the tissue with 0.1 N 
hydrochloric acid. Radioactivity in the withdrawn 
samples was determined in liquid scintillation 
counting with 50% efficiency. The induced [3H]- 
NA release during the stimulation period was ex- 
pressed as a percentage of total tritium present at 
the onset of stimulation. 
3. RESULTS 
3.1. Stimulation of [3HJNA release by K’ (25 mM) 
in cerebral cortical slices 
Rat cerebral cortical slices prelabeled with 
[3H]NA were allowed to reach a steady spon- 
taneous flow of radioactivity, and at t = 60 min 
were exposed to 25 mM KC1 for 10 min. An evoked 
release of [3H]NA of 8.6 + 0.4% of total tissue 
[3H]NA, above spontaneous release, was observed 
(fig.1). The K+ evoked release of [3H]NA was ab- 
Fig.1. Potassium-stimulated [3H]NA release. Rat 
cerebral cortical slices, prelabelled with [3H]NA were 
incubated with oxygenated medium, and the 
radioactivity released during 10 min periods was 
collected. At t=60 min, 25 mM KC1 (osmolality of the 
medium was corrected by lowering NaCl content, 
respectively) was added to the incubation medium for 10 
min (see hatched area). Fractional release was calculated 
as described in section 2. Each column represents the 
mean value of 4 independent determinations, and the 
bars depict SE. 
solutely dependent on the presence of Ca2+ in the 
medium (not shown). 
3.2. Stimulation of [3H]NA release by veratridine 
in cerebral cortical slices 
Cortical slices, prelabeled with [3H]NA were 
allowed to reach a steady spontaneous efflux of 
radioactivity, and at t =60 min, were exposed to 
3.0 ,uM veratridine for a period of 10 min. Vera- 
tridine, a veratrum alkaloid which depolarises ex- 
citable membranes, at 3.0 PM, caused a 13.4 & 
0.3% increase in [3H]NA fractional efflux above 
spontaneous release. The results represent the 
mean of quadruplicate determinations carried out 
twice (fig.2). At 3 PM veratridine, [‘H]NA release 
was absolutely dependent on extracellular calcium 
(not shown). 
3.3. Stimulation of fH]NA release by 15 mM K+ 
in rat brain synaptosomes 
Cortical synaptosomes prelabeled with [3H]NA 
were superfused with medium (gassed with 95% 
02/5% COz) at 37°C for 45 min. KC1 (15 mM) was 
added to the medium at t = 55 min for 2 min. The 
induced [3H]NA release, collected at 2 min inter- 
vals (see section 2), was 3-fold of the control super- 
fusion system run in parallel. The spontaneous 
s e i IO 3@M VERATRIDINE 
TIME, min 
Fig.2. Veratridine stimulation of [3H]NA release. Rat 
cerebral cortical slices prelabeled with [3H]NA were 
incubated with oxygenated medium, and the 
radioactivity released during 10 min periods was 
collected. At t = 60 min, 3 PM veratridine was added to 
the incubation medium for a 10 min interval (see hatched 
area). Fractional release was calculated as described in 
section 2. Each column represents the mean value of 4 
independent determinations, and the bars depict SE. 
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fractional [‘H]NA release was 2-2.590 of total 
[3H]NA in control, as compared to 6-7.5% of total 
[3H]NA in the stimulated system. 
3.4. The effect of neomycin on the K+-stimulated 
~H]NA release in cortical slices 
Neomycin, at indicated concentrations (fig.3), 
was added to rat cerebral cortical slices at t =40 
min, and was present in the medium throughout 
the experiment. The spontaneous [3H]NA frac- 
tional release during two lo-min intervals, was not 
affected by neomycin. At t = 60 min, the slices 
were stimulated by 25 mM K’ (fig.1) for 10 min. 
The total K+-induced .[3H]NA release was calcul- 
ated by subtracting the spontaneous efflux of 
radioactivity from the total [3H]NA released dur- 
ing the stimulation period and the following 10 
min interval. As shown in fig.3, the net fractional 
release decreases as a function of neomycin con- 
centration, with an apparent half-maximal effect, 
ICso =0.5 kO.07 mM (fig.3). The results are the 
mean value of four independent release systems. In 
all cases the SE was < 15% of the mean. 
NEOMYCIN, mM 
Fig.3. Effect of neomycin on 25 mM K’-induced 
[3H]NA release. Rat cortical slices labeled with [3H]NA, 
were stimulated with 25 mM K+ for 10 min at t = 60 min. 
Neomycin was added to the medium at t = 40 min, 20 
min prior to stimulation. Data are expressed as total 
K+-induced (3H]NA released in the absence and presence 
of neomycin at concentrations as indicated. Total 
[‘H]NA release induced by K+ was 8.5 f 0.6% of total 
tissue content of [3H]NA. Each point represents the 
mean f SE of 4 independent determinations (n = 4). 
3.5. The effect of neomycin on the veratridine- 
induced [3H]NA release in cortical slices 
Neomycin, at indicated concentrations, was added 
to rat cerebral cortical slices at t =40 min. After 
two lo-min intervals, during which no effect on 
[3H]NA spontaneous release was observed, at 
t =60 min, the slices were stimulated by 3.0 FM 
veratridine. The total veratridine-induced [3H]NA 
release was calculated by subtracting the spon- 
taneous efflux of radioactivity from the total 
[3H]NA released during the stimulation period and 
the following 20 min. As shown in fig.4, a decrease 
in the net stimulated [3H]NA release was observed 
as a function of neomycin concentration, with an 
apparent half-maximal effect, ICSO = 0.65 f 0.1 
mM. The result is the mean of four independent 
release systems. In all cases, the SE was < 15% of 
the mean. 
3.6. The effect of neomycin on the K’-induced 
~HJNA release in synaptosomes 
As shown in fig.5, neomycin inhibits the K+- 
stimulated release of t3H]NA from cortical synap- 
NEOMYCIN ,mM 
Fig.4. Effect of neomycin on varatridine-stimulated 
[3H]NA release. Cortical slices, labeled with [3H]NA, 
were stimulated with 3 PM veratridine at t = 60 min for 
10 min. Neomycin was added to the medium (at the 
indicated concentrations) 20 min prior to stimulation 
(t =40 min). Data are expressed as total veratridine- 
stimulated i3H]NA released in the absence and presence 
of neomycin. Total [3H]NA release induced by 
veratridine was 13.5 + 0.5% of [3H]NA tissue content. 
Each point represents the mean 5 SE of 4 independent 
determinations (n = 4). 
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Fig.5. Effect of neomycin on K+-induced [3H]NA 
release in brain cortical synaptosomes. Synaptosomes 
prepared from rat cortex, prelabeled with [3H]NA, were 
incubated with control oxygenated medium for 45 min. 
Stimulation was initiated by KC1 (15 mM), at t = 55 min 
for 2 min. Neomycin at the indicated concentrations was 
added 8 min prior to stimulation. [3H]NA release was 
calculated as the net [3H]NA after subtracting the 
spontaneous release (n =4). Each point represents 4 
independent release systems (n = 4) and the results are 
the average f SE of the net % stimulation. 
tosomes, with an apparent half-maximal effect, 
ICSO = 0.2kO.03 mM. 
4. DISCUSSION 
The mechanism via which calcium ions trigger 
neurotransmitter release is still unknown, and one 
of the essential points raised is the source of the 
calcium ions needed in the process. Recent studies 
have correlated the neomycin inhibitory effect of 
various Ca2+-dependent cellular processes with the 
availability of phosphatidylinositol 1 ,Zdiphos- 
phate for phospholipiase C [9-131. 
In the present study, neomycin inhibits the K+- 
and the veratridine-stimulated release of [3H]NA, 
from either cerebral cortical slices or synapto- 
somes, at half-maximal values of 0.2-0.7 mM. The 
50% inhibitory concentrations of neomycin are in 
the range of its affinity (K, = 0.53 mM) as a com- 
petitive inhibitor of phospholipase C in the soluble 
fractions of rat renal tissue [16]. Both K+ (25 mM) 
and veratridine (3 PM) stimulate neurotransmitter 
release as Ca2+-dependent processes, and both 
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were shown to increase the level of phosphoino- 
sitides [17], which is one of the routes for eliciting 
a rapid rise in intracellular calcium ions. Since 
stimulation of neurotransmitter release by K+ and 
veratridine depends on the presence of extracel- 
lular Ca2+ as recently shown using Fura- [ 181, and 
in both processes Ca2+ entry is essential, the ques- 
tion arises as to the role of intracellular Ca2+ in 
this process. 
Recently, Irvine and Moor [19] have provided 
indirect evidence to suggest that IP4, which is 
formed by phosphorylation of IP3, controls the en- 
try of extracellular calcium ions. They show that 
injection of IP3 into fertilized eggs leads to both an 
increase of intracellular Ca2+ and stimulation of 
Ca2+ influx across the cell membrane [19]. Thus, 
the inhibitory effect of neomycin, which selectively 
binds anionic phosphoinositides [l-6] as well as 
IP3 [14], can originate from lowering the amount 
of IP3 which consequently leads to a decrease in 
the amount of IP4. Therefore, neomycin is ex- 
pected to inhibit release processes which are depen- 
dent on Ca2+ influx across the cellular membrane 
as well as processes which involve Ca2+ mobiliza- 
tion from internal stores. 
Further support for this hypothesis can be de- 
rived from the report by Baird and Nahorski [20], 
who observed a rapid rise in IP4 formation, follow- 
ed by K+ stimulation of cortical rat brain slices. It 
is therefore essential to demonstrate that neomycin 
is able to lower IP3 and IP4 levels formed concomi- 
tant to the induction of neurotransmitter release by 
either K+ or veratridine. These experiments are 
now in progress. 
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